Every 10-Q that Addus Homecare Corp (ADUS) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow ADUS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ADUS filings page.
Addus HomeCare Corporation delivered higher results for the three and six months ended June 30, 2026. Net service revenues were $377.4 million for the quarter, up 8.0% from $349.4 million, and $741.0 million for the first half, up 7.8% from $687.2 million. Quarterly net income increased to $27.6 million, a 25.2% rise, and first-half net income reached $52.7 million, up from $43.3 million, with diluted EPS of $1.49 for the quarter and $2.85 year-to-date.
Growth was driven mainly by the personal care segment, which generated $296.0 million in Q2 revenue, supported by organic volume and the HomeCourt, Gold Horses and Helping Hands acquisitions. Hospice revenue rose to $64.2 million on organic growth, while home health revenue edged down to $17.2 million on lower patient volumes. Managed care organizations represented 38.6% of Q2 net service revenues, and Illinois personal care remained a key contributor, with the Illinois Department on Aging accounting for 17.7% of net service revenues in the quarter.
Cash generation and deleveraging were notable. Net cash provided by operating activities for the first half was $92.4 million, compared with $41.5 million a year earlier. Cash increased to $99.6 million, and long-term debt declined to $61.6 million from $121.0 million, after repaying $60.0 million on the revolving credit facility, leaving $577.8 million available to borrow. The company received $6.3 million of ARPA-related state funding in the first half, using $5.6 million primarily for caregiver recruitment and retention, and reported $12.4 million of deferred ARPA funding within government stimulus advances. The discussion highlights recent reimbursement increases in Illinois and Texas, a 2.6% Medicare hospice rate update, a projected 1.3% reduction in Medicare home health payments for 2026, CMS’s new Medicaid access rule with an 80/20 compensation requirement by mid-2030, and a six‑month nationwide moratorium on new Medicare hospice and home health enrollments.
Addus HomeCare Corporation reported solid growth for the quarter ended March 31, 2026. Net service revenues rose to $363.6 million from $337.7 million, driven mainly by higher personal care volumes and hospice census.
Net income increased to $25.1 million from $21.2 million, with diluted EPS of $1.36 versus $1.16. Personal care revenue grew 8.8% to $281.1 million, hospice 7.1% to $65.8 million, while home health declined 7.0% to $16.7 million as volumes fell but margins improved.
The company generated $52.4 million of operating cash flow, ended the quarter with $103.1 million in cash, and reduced revolver borrowings to $94.3 million. It also received $6.2 million of ARPA funding, with $14.6 million remaining deferred. After quarter-end, Addus acquired HomeCourt Home Care in Indiana for about $12.5 million, expanding its personal care footprint.
Addus HomeCare (ADUS) reported solid Q3 2025 growth, with net service revenues of $362.3 million, up from $289.8 million a year ago. Operating income rose to $32.9 million from $26.0 million, and net income increased to $22.8 million from $20.2 million. Diluted EPS was $1.24 versus $1.10.
Growth was broad-based: personal care delivered $275.8 million, hospice $68.9 million, and home health $17.6 million. For the first nine months, revenue reached $1.05 billion (from $857.5 million), with net income of $66.1 million (from $54.1 million) and diluted EPS of $3.60 (from $3.17). Cash from operations was $92.7 million.
Addus completed the Helping Hands acquisition on August 1 for approximately $21.4 million, adding $3.1 million of quarterly revenue and $0.4 million of operating income. The company continued to streamline its portfolio, progressing on the New York asset sale and recording $3.8 million in deferred payments year-to-date, with $2.3 million remaining as of September 30, 2025. Long-term revolver borrowings declined to $154.3 million from $223.0 million, and the company remained in compliance with credit covenants. Shares outstanding were 18,483,271 as of October 28, 2025.